To su u zajedničkom saopštenju objavili Centri za kontrolu i prevenciju bolesti i Uprava za hranu i lekove (FDA).
Today FDA and @CDCgov issued a statement regarding the Johnson & Johnson #COVID19 vaccine. We are recommending a pause in the use of this vaccine out of an abundance of caution.
— U.S. FDA (@US_FDA) April 13, 2021
Kako se navodi u saopštenju, u pitanju su žene stare između 18 i 48 godina kod kojih su se simptomi pojavili između šestog i 13. dana posle vakcinacije.
As of 4/12, 6.8m+ doses of the J&J vaccine have been administered in the U.S. CDC & FDA are reviewing data involving 6 reported U.S. cases of a rare & severe type of blood clot in individuals after receiving the vaccine. Right now, these adverse events appear to be extremely rare
— U.S. FDA (@US_FDA) April 13, 2021
„Centri za kontrolu bolesti su izuzetno zabrinuti i po tom pitanju pomno prate situaciju“, objavio je ranije Si-En-En izjavu neimenovanog eksperta.
CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases.
— U.S. FDA (@US_FDA) April 13, 2021
Vakcina „Džonson i Džonson“ u upotrebi je od 3. marta, a u Americi je dato više od 6,8 miliona doza.
Pročitajte još:
